Recommended dosing of UFH and LMWH in neonates and children.
UFH i.v. . | Neonates < 5kg . | Children > 5kg . | Target aPTT at 4h . |
---|---|---|---|
* 1 mg Enoxaparin = 110 anti-FXa units | |||
For UFH: aPTT 4 hours after loading dose and 4 hours after each dosage adjustment, at least once daily; keep AT level within normal range; daily blood count (platelets!). For LMWH: anti-FX activity 4 hours after injection | |||
loading dose | 1 × 75 U/kg/10 min | 1 × 75 U/kg/10 min | |
maintenance | 25–30 U/kg/h | 20 U/kg/h | 60–85 sec. |
LMWH s.c. | Neonates < 5kg | Children > 5kg | Target anti-FXa at 4 h |
initial treatment dose | |||
Enoxaparin* | 1 × 2.0 mg/kg/d | 1 × 1.5 mg/kg/d | 0.4–0.8 U/mL |
Dalteparin | 1 × 200 U/kg/d | 1 × 150 U/kg/d | 0.4–0.8 U/mL |
Reviparin | 2 × 150 U/kg/d | 2 × 100 U/kg/d | 0.5–1.0 U/mL |
initial prophylactic dose | |||
Enoxaparin* | 1 × 1.5 mg/kg/d | 1 × 1.0 mg/kg/d | < 0.4 U/mL |
Dalteparin | 1 × 100 U/kg/d | 1 × 50 U/kg/d | < 0.4 U/mL |
Reviparin | 2 × 50 U/kg/d | 2 × 30 U/kg/d | < 0.5 U/mL |
UFH i.v. . | Neonates < 5kg . | Children > 5kg . | Target aPTT at 4h . |
---|---|---|---|
* 1 mg Enoxaparin = 110 anti-FXa units | |||
For UFH: aPTT 4 hours after loading dose and 4 hours after each dosage adjustment, at least once daily; keep AT level within normal range; daily blood count (platelets!). For LMWH: anti-FX activity 4 hours after injection | |||
loading dose | 1 × 75 U/kg/10 min | 1 × 75 U/kg/10 min | |
maintenance | 25–30 U/kg/h | 20 U/kg/h | 60–85 sec. |
LMWH s.c. | Neonates < 5kg | Children > 5kg | Target anti-FXa at 4 h |
initial treatment dose | |||
Enoxaparin* | 1 × 2.0 mg/kg/d | 1 × 1.5 mg/kg/d | 0.4–0.8 U/mL |
Dalteparin | 1 × 200 U/kg/d | 1 × 150 U/kg/d | 0.4–0.8 U/mL |
Reviparin | 2 × 150 U/kg/d | 2 × 100 U/kg/d | 0.5–1.0 U/mL |
initial prophylactic dose | |||
Enoxaparin* | 1 × 1.5 mg/kg/d | 1 × 1.0 mg/kg/d | < 0.4 U/mL |
Dalteparin | 1 × 100 U/kg/d | 1 × 50 U/kg/d | < 0.4 U/mL |
Reviparin | 2 × 50 U/kg/d | 2 × 30 U/kg/d | < 0.5 U/mL |